GCT
DGX icon

Galaxy Capital Trading’s Quest Diagnostics DGX Stock Holding History

Galaxy Capital Trading’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$193K Buy
+3,600
New +$214K 0.48% 68
2013
Q3 		– Sell
-3,800
Closed -$230K – 216
2013
Q2 		$230K Buy
+3,800
New +$226K 0.2% 149

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AAM
Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.46% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Galaxy Capital Trading's DGX Position: Q4 2013 in Review

Galaxy Capital Trading opened a new position in Quest Diagnostics (DGX) in Q4 2013: 3,600 shares worth $193K. The stake represents 0.48% of the portfolio and ranks #68 among its holdings. This is a return to the name: Galaxy Capital Trading previously reported a position in DGX as recently as Q2 2013.

Galaxy Capital Trading first reported a position in DGX in Q2 2013 and has held it in 2 quarters since. The position peaked at $230K in Q2 2013. 455 funds tracked by Wall St. Rank hold DGX as of Q4 2013.

  • Galaxy Capital Trading held 3,600 shares of Quest Diagnostics worth $193K as of Q4 2013.
  • Quest Diagnostics was a new Galaxy Capital Trading position in Q4 2013.
  • Quest Diagnostics made up 0.48% of Galaxy Capital Trading's portfolio in Q4 2013, its #68 holding.
  • Galaxy Capital Trading first reported a position in Quest Diagnostics in Q2 2013 and has held it in 2 quarters since.
  • Galaxy Capital Trading's Quest Diagnostics position peaked at $230K in Q2 2013.
  • 455 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2013.

Based on Galaxy Capital Trading's 13F filing for Q4 2013, filed 26 Feb 2014.